Keywords: برونکودیلاتور; Photochemical reactions; Bronchodilator; FTIR-ATR; FT-Raman; UV-visible spectroscopic techniques; Spectral profiles; Drug compatibility and calibration curves;
مقالات ISI برونکودیلاتور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: برونکودیلاتور; Lung model; Ventilator; Bronchodilator; Vibrating mesh nebulizer; Small volume nebulizer;
Keywords: برونکودیلاتور; Aerosol; Bronchodilator; ENDS; Electronic cigarette; Thermal aerosol generation;
Keywords: برونکودیلاتور; bronchopulmonary dysplasia; prematurity; pulmonary morbidity; wheeze; BD; Bronchodilator; BPD; Bronchopulmonary dysplasia; ELGAN; Extremely low gestational age newborn; GA; Gestational age; ICS; Inhaled corticosteroids; iNO; Inhaled nitric oxide; NO CLD;
Keywords: برونکودیلاتور; Asthma; Adult-onset; Late-onset; Cluster analysis; Phenotypes; Follow-up; Longitudinal; Smoking; Obesity; Early-onset; ACOS; Asthma-COPD overlap syndrome; ACT; Asthma control test; AQ20; Airways Questionnaire 20; BD; Bronchodilator; COPD; Chronic obstruct
Keywords: برونکودیلاتور; Lung function; Wheezing; Infants; Bronchodilator;
Keywords: برونکودیلاتور; Enfisema; Muerte; Efectos adversos; Toxicidad de los fármacos; Broncodilatador; Emphysema; Death; Adverse effect; Drug toxicity; Bronchodilator;
Keywords: برونکودیلاتور; Nebulized magnesium sulfate; Asthma; Bronchodilator; Randomized controlled trial; Magnesium sulfate (PubChem CID: 24083);
Keywords: برونکودیلاتور; Cystic fibrosis; Asthma; Bronchodilator; Reversibility; Airway obstruction; Hyperreactivity;
Keywords: برونکودیلاتور; Asma; Broncodilatador; Fluticasona propionato; Formoterol fumarato; Glucocorticoides inhalados; Agonista β2-adrenérgico de acción largaAsthma; Bronchodilator; Fluticasone propionate; Formoterol fumarate; Inhaled corticosteroid; Long-acting β2-agonist
Keywords: برونکودیلاتور; Bronchodilator; XRD; HF/DFT; FT-IR; FT-Raman; HOMO–LUMO
Keywords: برونکودیلاتور; Airway inflammation; Airway remodeling; Airway reversibility; Bronchodilator; Lung function; ACT; Asthma Control Test; BDR; Bronchodilator reversibility; FeNO; Exhaled nitric oxide fraction; FEV1; Forced expiratory volume in 1 second; FVC; Forced vital ca
Keywords: برونکودیلاتور; Asthma; Inhaled corticosteroid; Bronchodilator; Long-acting β2 agonist
Keywords: برونکودیلاتور; Corticosteroids; bronchodilator; cytokine; chemokine; IgE; kinase; p38 mitogen-activated protein kinase; bronchial thermoplasty; corticosteroid resistance; macrolide; ACOS; Asthma-chronic obstructive pulmonary disease overlap syndrome; COPD; Chronic obs
Keywords: برونکودیلاتور; Black pepper; Piper nigrum; Piperine; Bronchodilator; Phosphodiesterase inhibitor; Calcium channel blockerPapaverine (PubChem CID: 4680); Piperidine (PubChem CID: 8082); Piperine (PubChem CID: 638024); Verapamil (PubChem CID: 2520)
Keywords: برونکودیلاتور; Inflammatory airway disease; Recurrent airway obstruction; Bronchodilator; Environmental remediation; Airway inflammation; Corticosteroid; Lung function;
Keywords: برونکودیلاتور; Vasicinone; Quinazoline; Synthesis; Bronchodilator; Toxicity;
Keywords: برونکودیلاتور; BD; bronchodilator; GHS; general health status; GOLD; Global Initiative for Chronic Obstructive Lung Disease; LLN; lower limit of normal; PLATINO; Latin American Project for the Investigation of Obstructive Lung Disease; PR; prevalence ratio; SF-12; Short
Keywords: برونکودیلاتور; Chronic obstructive pulmonary disease; Clinical practice guidelines; Primary care physician; Guideline adherence; Bronchodilator;
Taste and smell GPCRs in the lung: Evidence for a previously unrecognized widespread chemosensory system
Keywords: برونکودیلاتور; Receptor; G-protein; Smooth muscle; Asthma; Bronchodilator; Airway;
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD
Keywords: برونکودیلاتور; CANO; alveolar concentration of nitric oxide; COPD; chronic obstructive pulmonary disease; CV; closing volume; CC; closing capacity; DLCO; diffusion lung capacity for carbon monoxide; FENO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
Keywords: برونکودیلاتور; Severe asthma; Asthma phenotypes; BD; Bronchodilator; BMI; Body mass index; DCC; Data coordinating center; FeNO; Fraction expired nitric oxide; FEV1; Forced expired volume in 1 second; FEV1/FVC; Forced expired volume in 1 second/forced vital capacity rati
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
Keywords: برونکودیلاتور; Bronchodilator; COPD; Long-acting muscarinic antagonist; Revefenacin; Rapid onset; Nebulized; Once-daily; Inhalation; Anti-muscarinic;
Effect of a single exacerbation on decline in lung function in COPD
Keywords: برونکودیلاتور; PFT; Pulmonary function test; UPLIFT®; Understanding Potential Long-term Impacts on Function with Tiotropium; Bronchodilator; COPD; Exacerbation; Lung function decline; Tiotropium;
Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease
Keywords: برونکودیلاتور; COPD; Cardiovascular disease; Heart failure; Beta-blocker; Bronchodilator;
Responsiveness to bronchodilator procaterol in COPD as assessed by forced oscillation technique
Keywords: برونکودیلاتور; Airway; Airway smooth muscle; Forced oscillation technique; Impedance; Bronchodilator; Procaterol;
Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD
Keywords: برونکودیلاتور; asthma; COPD; omalizumab; respiratory care; targeted therapy; ACQ-5; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; AXR; Australian Xolair Registry; BD; bronchodilator; GINA; Global Initiative for Asthma; ICS; inhaled corticoste
Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β2-adrenoceptor agonist (MABA) molecule
Keywords: برونکودیلاتور; COPD; Bronchodilator; Long-acting β2-adrenoceptor agonist; Long-acting muscarinic antagonist; ACh; acetylcholine; ANOVA; analysis of variance; β; beta-adrenoceptor; cAMP; cyclic adenosine monophosphate; CHO; Chinese hamster ovary; CI; confidence interva
Reduced COPD Exacerbation Risk Correlates With Improved FEV1
Keywords: برونکودیلاتور; COPD exacerbations; COPD mechanisms; COPD pharmacology; BD; bronchodilator; dFEV1; between-group difference in change in predose (trough) FEV1 from the beginning to the end of the trial; HR; hazard ratio; non-BD; nonbronchodilator; PDE4; phosphodiesterase
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Keywords: برونکودیلاتور; β2-agonist; bronchodilator; chronic bronchitis; emphysema; muscarinic antagonists; AE; adverse event; ATS; American Thoracic Society; CAT; COPD Assessment Test; DPI; dry powder inhaler; FDC; fixed-dose combination; FEV1 AUC0-12; FEV1 area under the curv
Investigation of the efficacy of generic and brand-name tiotropium bromide in the management of chronic obstructive pulmonary disease: A randomized comparative trial
Keywords: برونکودیلاتور; Chronic obstructive pulmonary disease; Anticholinergic; Bronchodilator; Tiotropium bromide; Generic; Randomized controlled trial
Fifteen-year mortality of patients with asthma-COPD overlap syndrome
Keywords: برونکودیلاتور; 6MWT; 6-min walking test; ACOS; asthma-COPD overlap syndrome; BD; bronchodilator; COPD; chronic obstructive pulmonary disease; GLI; Global Lung Initiative; HRQL; health-related quality of life; LLN; lower limit of normal; PY; person/years; SA.R.A.; SAlu
Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study
Keywords: برونکودیلاتور; COPD; Primary care; Bronchodilator; PUMA; TreatmentBD, bronchodilator; CS, corticosteroid; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; LABA, long-acting β-agonist; LA-BD, long-acting bronchodilator; LAMA, long-acting muscarinic anta
Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
Keywords: برونکودیلاتور; Bronchodilator; Chronic obstructive pulmonary disease; Safety; Glycopyrrolate; Long-acting muscarinic antagonist; Indacaterol;
Anti-cholinergic and Ca2+-antagonist mechanisms explain the pharmacological basis for folkloric use of Sisymbrium irio Linn. in gastrointestinal, airways and vascular system ailments
Keywords: برونکودیلاتور; Atropine sulfate (CID: 5927); Carbachol/Carbamylcholine chloride (CID: 5831); Verapamil hydrochloride (CID: 2520); Phenylephrine (CID: 6041); Dicyclomine (CID: 3042); Gut modulator; Vasodilator; Bronchodilator; Acute toxicity; Sisymbrium irio Linn;
Effect of tiotropium on neural respiratory drive during exercise in severe COPD
Keywords: برونکودیلاتور; Bronchodilator; Diaphragmatic EMG; Dyspnea; Efficiency of neural respiratory drive; Exercise tolerance; Muscarinic receptor antagonist; IC; inspiratory capacity; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; FRC; functional res
Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the β2 adrenoceptor
Keywords: برونکودیلاتور; Bronchodilator; Boron; Guinea pig; Docking; β2 adrenoceptor agonist; GPCRs;
Molecular hybridization yields triazole bronchodilators for the treatment of COPD
Keywords: برونکودیلاتور; MABA; Inhalation by design; COPD; Bronchodilator; Bifunctional;
Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials
Keywords: برونکودیلاتور; Bronchodilator; Cystic fibrosis; Respimat; Tiotropium
Daily variation in lung function in COPD patients with combined albuterol and ipratropium: Results from a 4-week, randomized, crossover study
Keywords: برونکودیلاتور; Bronchodilator; COPD; Short-acting β2-agonist; Short-acting muscarinic antagonist;
Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study
Keywords: برونکودیلاتور; Aclidinium bromide; Glycopyrronium bromide; COPD; Hyperinflation; Dyspnoea; Bronchodilator;
Original ResearchAsthmaImproved Criterion for Assessing Lung Function Reversibility
Keywords: برونکودیلاتور; BD; bronchodilator; BDR; bronchodilator reversibility; HR; hazard ratio; ICS; inhaled corticosteroid; +ve; positive; SR; standardized residual;
Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors
Keywords: برونکودیلاتور; Chronic obstructive pulmonary disease (COPD); Bronchodilator; β2-Adrenoceptor agonist; PDE4 inhibitor;
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD
Keywords: برونکودیلاتور; β2-Adrenoceptor agonist; Inhaled; LABA; Bronchodilator; Multivalent approach;
Multivalent design of long-acting β2-adrenoceptor agonists incorporating biarylamines
Keywords: برونکودیلاتور; β2-Adrenoceptor agonist; Inhaled; LABA; Bronchodilator; Multivalent approach
Native American Ancestry, Lung Function, and COPD in Costa Ricans
Keywords: برونکودیلاتور; BD; bronchodilator; HGDP; Human Genome Diversity Project; LAMP; Local Ancestry in Admixed Populations; SNP; single-nucleotide polymorphism;
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist
Keywords: برونکودیلاتور; β2-Adrenoceptor agonist; Bronchodilator; Chronic obstructive pulmonary disease;
Partial versus maximal forced exhalations in COPD: Enhanced signal detection for novel therapies
Keywords: برونکودیلاتور; Spirometry; Partial expiratory flow-rate; Bronchodilator; COPD
Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: A randomised dose-ranging study
Keywords: برونکودیلاتور; Tiotropium; Anticholinergic; Bronchodilator; Asthma; Adolescents; Inhaled corticosteroids;
Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD
Keywords: برونکودیلاتور; COPD; Bronchodilator; β2-Adrenoceptor agonist; PDE4 inhibitor;